Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-01

Clinical Trial Update: Alcohol Use Disorder and Cannabidiol [Phase 2, Phase 3]

View source ↗

Summary

An ongoing Phase 2/3 clinical trial is evaluating cannabidiol for alcohol use disorder and is currently recruiting, sponsored by the University of Colorado, Den…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Alcohol Use Disorder | Phase 2, Phase 3 | Status: RECRUITING